Crowdonomics
WatchlistPortfolio
All companies

TAXA Biotechnologies, Inc

Operating

Biotech · San Francisco, CA

Visit website
Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$309,807
Across 1 round since 2016

Financials

FY2014–FY2016 · from SEC filings · hover any figure for its source
$1K
−$361K
2014
$6K
−$299K
2015
$4K
−$367K
2016
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2014 reviewed*
FY2015 reviewed*
FY2016
Income statement
Revenue
$1,115
$5,694
$3,892
Cost of goods sold
$0
$0
$0
Gross margin
100%
100%
100%
Net income
-$361,237
-$298,573
-$366,880
Taxes paid
$0
$1,247
$1,457
Balance sheet
Cash
$432,140
$193,376
$182,977
Accounts receivable
$0
$1,097
$0
Total assets
$441,532
$230,909
$223,265
Short-term debt
$569,251
$589,120
$581,161
Long-term debt
$441,532
$423,000
$732,807
Total liabilities
$1,010,783
$1,012,120
$1,313,968
Other
Headcount
—
3
3

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Reg CF · SAFE · May 2016Closedvia WeFunder
Raised $309.8K / $1M

Team

1 person
Antony Evans
CEO

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Possibly delinquent

Filed 1 of 10 annual reports (FY2016–FY2025)

Missing: 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARMay 2, 20170001670254-17-000089
    EDGAR
  • Form C-UNov 23, 20160001670254-16-000205
    EDGAR
  • Form C-UAug 18, 20160001670254-16-000099
    EDGAR
  • Form C/AAug 2, 20160001670254-16-000081
    EDGAR
  • Form C/AJun 1, 20160001670254-16-000054
    EDGAR
  • Form C/AJun 1, 20160001670254-16-000053
    EDGAR
  • Form CMay 16, 20160001670254-16-000002
    EDGAR
Source: SEC EDGARCIK 0001674082DELast synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.